Introduction:
We assess the impact of traditional prognostic factors, tumour location, degree of hydronephrosis and diabetes mellitus (DM) on the survival of patients treated for upper urinary tract urothelial carcinoma (UUTUC).
Methods:
From January 2004 to March 2010, we analyzed data from 114 patients with UUTUC who underwent nephroureterectomy with a bladder cuff excision. Median patient age was 71 years and median follow-up was 26.5 months. The influence of traditional prognostic factors, including DM, tumour stage, grade, location and degree of hydronephrosis, on recurrence-free survival (RFS) rates were analyzed using Kaplan-Meier analysis and Cox proportional hazards regression model.
Results:
Among 61 renal pelvis and 53 ureteral tumour cases, recurrence was identified in 71 cases (62.3%). Kaplan-Meier analysis showed that degree of hydronephrosis was associated with RFS (p = 0.001). DM and degree of hydronephrosis were independent factors for RFS in Cox proportional regression analysis (HR=1.8 CI: 1.01-3.55, p = 0.04), (HR=3.7, CI: 2.0-6.5, p = 0.001). All patients with ureteral tumour had no worse prognosis than those with renal pelvis tumour, but the pT2 patients with ureteral tumour had a worse prognosis than those with renal pelvis tumour with a median RFS of 9 months (range: 2.6-15.3 months) and 29 months (range: 8.0-13.2 months), respectively (p = 0.028).
Conclusions:
Tumour location is not a factor influencing RFS, except in the pT2 stage. However, severe hydronephrosis is associated with a higher recurrence in UUTUC. Also, DM is related to disease recurrence. Further prospective studies are needed to establish the prognostic significance of DM in large populations.
Citing Articles
Outcomes of laparoscopic, robotic and open nephroureterectomy with bladder cuff excision in patients with T3T4 upper urinary tract urothelial carcinoma: a multi-center retrospective study.
Fang J, Yeh H, Lee H, Weng H, Tai T, Huang C
BMC Urol. 2024; 24(1):231.
PMID: 39434129
PMC: 11492713.
DOI: 10.1186/s12894-024-01622-5.
The Value of Preoperative Local Symptoms in Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Retrospective, Multicenter Cohort Study.
Yeh H, Chang C, Fang J, Chen I, Lin J, Hong J
Front Oncol. 2022; 12:872849.
PMID: 35719933
PMC: 9201473.
DOI: 10.3389/fonc.2022.872849.
Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma.
Kim S, Song M, Joung J, Chung J, Lee K, Seo H
Investig Clin Urol. 2019; 60(6):432-442.
PMID: 31692890
PMC: 6821986.
DOI: 10.4111/icu.2019.60.6.432.
Identification of Significant Prognostic Tissue Markers Associated with Survival in Upper Urinary Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy: A Retrospective Immunohistochemical Analysis Using Tissue Microarray.
Kim S, Park W, Park B, Chung J, Joung J, Lee K
Cancer Res Treat. 2019; 52(1):128-138.
PMID: 31291718
PMC: 6962485.
DOI: 10.4143/crt.2019.119.
Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy.
Itami Y, Miyake M, Tatsumi Y, Gotoh D, Hori S, Morizawa Y
Int J Clin Oncol. 2019; 24(5):533-545.
PMID: 30604161
DOI: 10.1007/s10147-018-01381-y.
Clinical and prognostic value of preoperative hydronephrosis in upper tract urothelial carcinoma: a systematic review and meta-analysis.
Tian Y, Gong Y, Pang Y, Wang Z, Hong M
PeerJ. 2016; 4:e2144.
PMID: 27366646
PMC: 4924132.
DOI: 10.7717/peerj.2144.
Poor Preoperative Glycemic Control Is Associated with Dismal Prognosis after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Korean Multicenter Study.
Kang S, Hwang E, Jung S, Yu H, Chung H, Kang T
Cancer Res Treat. 2016; 48(4):1293-1301.
PMID: 27034146
PMC: 5080827.
DOI: 10.4143/crt.2016.021.
Predictive role of preoperative hydronephrosis on poor pathological outcomes and prognosis in upper tract urothelial carcinoma patients: Experience from a nationwide high-volume center in China.
Zhang Z, Fang D, Chen X, Li X, Xiong G, Zhang L
Oncol Lett. 2016; 10(5):3113-3122.
PMID: 26722298
PMC: 4665826.
DOI: 10.3892/ol.2015.3653.
Impact of stage and comorbidities on five-year survival after radical cystectomy in Poland: single centre experience.
Dybowski B, Ossolinski K, Ossolinska A, Peller M, Bres-Niewada E, Radziszewski P
Cent European J Urol. 2015; 68(3):278-83.
PMID: 26568866
PMC: 4643711.
DOI: 10.5173/ceju.2015.620.
Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial Carcinoma.
Yeh H, Jan H, Wu W, Li C, Li W, Ke H
PLoS One. 2015; 10(10):e0139624.
PMID: 26469704
PMC: 4607422.
DOI: 10.1371/journal.pone.0139624.
Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer.
Xu T, Zhu Z, Wang X, Xia L, Zhang X, Zhong S
Int Urol Nephrol. 2015; 47(7):1135-41.
PMID: 26009259
DOI: 10.1007/s11255-015-1013-1.
Predictors of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: an inflammation-based prognostic score.
Cho Y, Seo Y, Chung S, Hwang I, Yu H, Kim S
Korean J Urol. 2014; 55(7):453-9.
PMID: 25045443
PMC: 4101114.
DOI: 10.4111/kju.2014.55.7.453.